ChemAbout
© 2026 ChemAbout
인사이트|개인정보 처리방침|이용약관|[email protected]
홈/화합물/의약 중간체/(Ser(tBu)6,Azagly10)-LHRH
C59H84N18O14
1269.4 g/mol
의약 중간체경고

(Ser(tBu)6,Azagly10)-LHRH

CAS184686-52-0
용도 분류
의약 중간체
화합물 분류
펩타이드
주요 용도
의약 중간체

(Ser(tBu)6,Azagly10)-LHRH is a peptide analog intermediate used in the synthesis of LHRH (luteinizing hormone-releasing hormone) analogs. It features a tert-butyl-protected serine at position 6 and an azaglycine residue at position 10, and its structure includes multiple amide bonds and aromatic rings.

Pharmaceutical intermediate for LHRH peptide analog manufacturingReagent for peptide synthesis research

콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.

이 화합물을 구매하거나 공급하시겠습니까?

재고를 등록하거나 구매 요청을 게시하세요

CAS 184686-52-0

이 제품 등록하기
로그인 후 공급 정보 게시
이 제품 구매 요청
가입 없이 요청 제출

관련 화합물

참고동일 카테고리

1-Benzyl-3-aminopyrrolidine

CAS18471-40-4

pharmaceutical intermediate

참고동일 카테고리

Isopropyl 2-chloro-4-(1-methyl-1H-indol-3-yl)pyrimidine-5-carboxylate

CAS1847463-39-1

Pharmaceutical intermediate for synthesis

참고동일 카테고리

4-Amino-1,1,1-trifluorobut-3-en-2-one

CAS184848-89-3

Pharmaceutical intermediate

참고동일 카테고리

4-phenylbutanoyl chloride

CAS18496-54-3

Pharmaceutical intermediate

참고stereoisomer of

Goserelin Impurity G

CAS1926163-37-2

goserelin impurity reference standard

참고stereoisomer of

(D-Ser(tBu)6,D-Leu7,Azagly10)-LHRH

CAS1926163-38-3

LHRH analog peptide

참고stereoisomer of

(2S)-1-((2S)-2-((2S)-2-((2R)-3-(tert-butoxy)-2-((2S)-2-((2R)-3-hydroxy-2-((2S)-2-((2S)-3-(1H-imidazol-5-yl)-2-(((2S)-5-oxopyrrolidin-2-yl)formamido)propanamido)-3-(1H-indol-3-yl)propanamido)propanamido)-3-(4-hydroxyphenyl)propanamido)propanamido)-4-methylpentanamido)-5-carbamimidamidopentanoyl)-N-(carbamoylamino)pyrrolidine-2-carboxamide

CAS1926163-39-4

active pharmaceutical ingredient

참고stereoisomer of

Goserelin

CAS65807-02-5

active pharmaceutical ingredient

안전 참조

건강 유해
건강 유해
경고
H361Suspected of damaging fertility or the unborn child
식별자
IUPAC 이름

(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[(carbamoylamino)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide

InChIKey

BLCLNMBMMGCOAS-DXYQMANYSA-N

SMILES

CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NNC(=O)N)NC(=O)[C@H](COC(C)(C)C)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)NC(=O)[C@@H]6CCC(=O)N6

동의어 목록 (8)
  • Goserelin EP Impurity B
  • (Ser(tBu)6,Azagly10)-LHRH
  • GOSERELIN IMPURITY B